These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 18640479)

  • 1. Analysis of predictive value of four risk models in Medicaid recipients with chronic obstructive pulmonary disease in Texas.
    Yarger S; Rascati K; Lawson K; Barner J; Leslie R
    Clin Ther; 2008; 30 Spec No():1051-7. PubMed ID: 18640479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
    Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
    Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a diagnosis-based risk adjustment model to estimate costs of indigent care in a community at Medicaid reimbursement rates.
    Leslie RC; Shepherd MD; Simmons SC
    J Med Econ; 2008; 11(4):585-600. PubMed ID: 19450069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finding future high-cost cases: comparing prior cost versus diagnosis-based methods.
    Ash AS; Zhao Y; Ellis RP; Schlein Kramer M
    Health Serv Res; 2001 Dec; 36(6 Pt 2):194-206. PubMed ID: 16148969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the costs of chronic obstructive pulmonary disease: the state medicaid perspective.
    Marton JP; Boulanger L; Friedman M; Dixon D; Wilson J; Menzin J
    Respir Med; 2006 Jun; 100(6):996-1005. PubMed ID: 16288858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-adjusted capitation based on the Diagnostic Cost Group Model: an empirical evaluation with health survey information.
    Lamers LM
    Health Serv Res; 1999 Feb; 33(6):1727-44. PubMed ID: 10029506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the costs of managing patients with chronic obstructive pulmonary disease.
    Mapel DW; McMillan GP; Frost FJ; Hurley JS; Picchi MA; Lydick E; Spencer MD
    Respir Med; 2005 Oct; 99(10):1325-33. PubMed ID: 16140232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic implications of comorbid conditions among Medicaid beneficiaries with COPD.
    Lin PJ; Shaya FT; Scharf SM
    Respir Med; 2010 May; 104(5):697-704. PubMed ID: 19954941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the predictive validity of diagnosis-based risk adjusters for clinical outcomes.
    Petersen LA; Pietz K; Woodard LD; Byrne M
    Med Care; 2005 Jan; 43(1):61-7. PubMed ID: 15626935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using risk-adjustment models to identify high-cost risks.
    Meenan RT; Goodman MJ; Fishman PA; Hornbrook MC; O'Keeffe-Rosetti MC; Bachman DJ
    Med Care; 2003 Nov; 41(11):1301-12. PubMed ID: 14583693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis.
    Khanna R; Smith MJ
    Clin Ther; 2007 Nov; 29(11):2456-67. PubMed ID: 18158087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic burden prior to COPD diagnosis: a matched case-control study in the United States.
    Akazawa M; Halpern R; Riedel AA; Stanford RH; Dalal A; Blanchette CM
    Respir Med; 2008 Dec; 102(12):1744-52. PubMed ID: 18760581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
    Chiang CH
    Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
    Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H
    Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting pharmacy costs and other medical costs using diagnoses and drug claims.
    Zhao Y; Ash AS; Ellis RP; Ayanian JZ; Pope GC; Bowen B; Weyuker L
    Med Care; 2005 Jan; 43(1):34-43. PubMed ID: 15626932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting costs of care using a pharmacy-based measure risk adjustment in a veteran population.
    Sales AE; Liu CF; Sloan KL; Malkin J; Fishman PA; Rosen AK; Loveland S; Paul Nichol W; Suzuki NT; Perrin E; Sharp ND; Todd-Stenberg J
    Med Care; 2003 Jun; 41(6):753-60. PubMed ID: 12773841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring population health risks using inpatient diagnoses and outpatient pharmacy data.
    Zhao Y; Ellis RP; Ash AS; Calabrese D; Ayanian JZ; Slaughter JP; Weyuker L; Bowen B
    Health Serv Res; 2001 Dec; 36(6 Pt 2):180-93. PubMed ID: 16148968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K; Targowski T; From S
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs of chronic obstructive pulmonary disease (COPD) in Italy: the SIRIO study (social impact of respiratory integrated outcomes).
    Dal Negro RW; Tognella S; Tosatto R; Dionisi M; Turco P; Donner CF
    Respir Med; 2008 Jan; 102(1):92-101. PubMed ID: 17881206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.